NeuroCores, Inc.
Exhibitor
NeuroCores, Inc. is a preclinical biotech company that is revolutionizing the treatment of rare pediatric diseases.
Our lead asset is KIT-13, a novel oral small molecule drug targeting Rett Syndrome, a rare genetic neurological disorder.
NeuroCores is developing first-in-class drugs based on synthetic plasmalogen derivatives. Plasmalogen is the predominant phospholipid found in cell membranes. It serves as the most potent endogenous antioxidant and plays a crucial role in normal neuronal signaling, lipid homeostasis, and the fluidity and stability of biomembranes. NeuroCores has successfully developed an oral small molecule that can increase levels of plasmalogen in the brain, suppress neuroinflammation, restore mitochondrial membrane potential, and induce BDNF expression.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events